Oscar Health, Inc.·4

Jun 4, 4:15 PM ET

Blackley Richard Scott 4

Research Summary

AI-generated summary

Updated

Oscar Health (OSCR) CFO Richard Blackley Sells Shares

What Happened

  • Richard Scott Blackley, Chief Financial Officer of Oscar Health, reported sales of company stock on June 2, 2026. He disposed of 22,706 shares at a weighted-average price of $21.74 (proceeds $493,628) and 8,977 shares at a weighted-average price of $22.45 (proceeds $201,534), for combined gross proceeds of approximately $695,162. These were sales (not purchases) and were effected under a pre-existing Rule 10b5-1 plan to satisfy tax-withholding obligations related to equity vesting.

Key Details

  • Transaction dates: June 2, 2026; Form 4 filed June 4, 2026 (appears timely).
  • Share details:
    • 22,706 shares sold @ weighted avg $21.74 — reported range $21.03–$22.02 (footnote F2).
    • 8,977 shares sold @ weighted avg $22.45 — reported range $22.03–$22.96 (footnote F4).
    • Total sold: 31,683 shares for ~$695,162.
  • Footnotes of note:
    • F1: Sales were made pursuant to a Rule 10b5-1 instruction letter (dated Aug 8, 2025) to satisfy tax withholding on vested awards.
    • F3: Some shares relate to shares to be issued upon vesting of restricted stock units (RSUs).
    • F2/F4: Weighted-average prices reported; the filer will provide per-price breakdowns on request.
  • Shares owned after the transaction: not specified in the information provided in your prompt (check the full Form 4 for post-transaction ownership).

Context

  • These were open-market sales executed under a pre-set 10b5-1 plan and to cover tax withholding for vested awards; such transactions are typically routine and do not necessarily signal a change in insider confidence. Retail investors often view purchases as stronger signals than planned sales.